Meta-analysis: hyperhomocysteinaemia in inflammatory bowel diseases.
about
Inflammatory bowel disease: an increased risk factor for neurologic complicationsVenous thrombosis and prothrombotic factors in inflammatory bowel disease.Associations between Folate and Vitamin B12 Levels and Inflammatory Bowel Disease: A Meta-Analysis.Effect of homocysteine on intestinal permeability in rats with experimental colitis, and its mechanismDietary folate does not significantly affect the intestinal microbiome, inflammation or tumorigenesis in azoxymethane-dextran sodium sulphate-treated mice.Venous and arterial disease in inflammatory bowel disease.Hyperhomocysteinemia as a potential contributor of colorectal cancer development in inflammatory bowel diseases: a review.Cardiovascular complications in inflammatory bowel disease.Thrombosis in inflammatory bowel diseases: what's the link?Decreased Plasma Histidine Level Predicts Risk of Relapse in Patients with Ulcerative Colitis in RemissionHyperhomocysteinemia decreases intestinal motility leading to constipation.Homocysteine imbalance: a pathological metabolic markerEnteropathic spondyloarthritis: from diagnosis to treatment.Inflammatory bowel disease: epidemiology, pathology and risk factors for hypercoagulability.The association of the MTHFR C677T polymorphism with inflammatory bowel diseases in the Israeli Jewish population: An example of genetic heterogeneity.Mitochondrial mitophagy in mesenteric artery remodeling in hyperhomocysteinemia.Potential value of nutrigenomics in Crohn's disease.Extraintestinal manifestations and complications in IBD.Thromboembolic complications in inflammatory bowel disease.Epidemiology, risk factors and management of cardiovascular diseases in IBD.Overview of venous thrombosis in inflammatory bowel disease.The relationship between coagulation state and inflammatory bowel disease: current understanding and clinical implications.Effects of Collagen Crosslinking on Bone Material Properties in Health and Disease.Association of MTHFR gene C677T mutation with recurrent aphthous stomatitis and number of oral ulcers.Hyperhomocysteinemia in patients with Crohn's disease.Short-term effect of infliximab is reflected in the clot lysis profile of patients with inflammatory bowel disease: a prospective study.Portomesenteric vein thrombosis in patients with inflammatory bowel disease
P2860
Q27690759-EABAD104-351D-4ECE-B27C-07C4A7AB6B4CQ33564092-85A55948-1069-4D28-9B56-30BF1B26776CQ33616856-E0B58032-8BF7-494B-A41B-C7EF56EAAFDFQ34012514-17C528C1-C9AF-4C1E-8AD1-47399139919FQ34424300-0D42B19D-EB39-45B9-BDAA-AAB9A910DD9CQ34714365-1D2DBF9B-1458-44C8-949E-8B07D3FDEEC5Q35012018-ECE63DCC-C632-4B8E-88D4-997151321051Q35197222-9315FAC3-38FC-449A-97C3-AD02ED9850A1Q35368162-F9CB2009-659F-43CB-A8E6-010D9944AF93Q35810516-02B3F017-EAB8-49CD-AFDF-E5315D2B3497Q36175923-15614AD3-7441-4313-B731-FB140A9EF3F5Q36828666-0D4442E7-C85B-45D8-A846-B493A9FA2D7EQ36830824-AE542F27-047A-4776-ADC2-7645CF56DDE4Q37454573-37DA2A62-2978-4122-9279-DEE2B82B3752Q37530552-39EAD456-D23D-4ED2-81E2-2FA1E429B13AQ37727246-A0866DC5-D624-4761-9393-6352A1E092EBQ37992788-1B8CEDF3-3C5C-47D4-9A98-1C326C399EE6Q38120146-2843715F-2315-4E76-9F96-8E47FD00F133Q38239252-B3BCB031-DBF8-4CF3-9D3C-0FCBF7BC0810Q38275040-1354D1B9-35E2-4663-B67D-E7A9E5360A11Q38315631-304E8BCF-DD06-4BE0-98A0-1DB2C671AEEFQ38365449-224D1117-69A7-44FE-891B-6F0F954A39A1Q38384409-0C7CEC74-F27B-4656-BC22-1F0BEE72E441Q43697511-54278E65-AC27-4352-8D08-8E187CB97BCCQ45730838-A33BE331-C227-4EAA-BC3F-97DE6E28263AQ53617328-18B74615-FEC0-46BC-9D45-143107937275Q57643472-024F04CD-C583-42B3-B387-FBFE64E8EA76
P2860
Meta-analysis: hyperhomocysteinaemia in inflammatory bowel diseases.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Meta-analysis: hyperhomocysteinaemia in inflammatory bowel diseases.
@en
Meta-analysis: hyperhomocysteinaemia in inflammatory bowel diseases.
@nl
type
label
Meta-analysis: hyperhomocysteinaemia in inflammatory bowel diseases.
@en
Meta-analysis: hyperhomocysteinaemia in inflammatory bowel diseases.
@nl
prefLabel
Meta-analysis: hyperhomocysteinaemia in inflammatory bowel diseases.
@en
Meta-analysis: hyperhomocysteinaemia in inflammatory bowel diseases.
@nl
P2093
P921
P1476
Meta-analysis: hyperhomocysteinaemia in inflammatory bowel diseases.
@en
P2093
A Oussalah
J-L Guéant
L Peyrin-Biroulet
P304
P356
10.1111/J.1365-2036.2011.04864.X
P407
P577
2011-10-03T00:00:00Z